US 11433088
Methods for treatment of vascular endothelial dysfunction using nicotinamide mononucleotide
granted A61KA61K31/706A61P
Quick answer
US patent 11433088 (Methods for treatment of vascular endothelial dysfunction using nicotinamide mononucleotide) held by The Regents of the University of Colorado, a Body Corporate expires Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue Sep 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/706, A61P, A61P39/00